Bio-Techne (TECH) Research & Development (2009 - 2026)
Bio-Techne's quarterly Research & Development came in at $23.5 million in Q1 2026, down 4.57% year-on-year from $24.6 million in Q1 2025, and up 1.43% quarter-over-quarter from $23.1 million in Q4 2025.
Bio-Techne has reported Research & Development for 18 years, with the latest figure at $23.5 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 4.57% year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $96.9 million (down 0.62% YoY), and the FY2025 full-year result was $99.5 million, up 2.93% from the prior year.
- Research & Development for Q1 2026 stood at $23.5 million, up from $23.1 million in the prior quarter.
- The five-year high for Research & Development was $26.0 million in Q2 2025, with the low at $21.7 million in Q1 2022.
- Average Research & Development over 5 years is $23.8 million, with a median of $23.9 million recorded in 2024.
- Year-over-year, Research & Development increased 27.5% in 2022 and retreated 7.56% in 2025.
- Tracing TECH's Research & Development over 5 years: stood at $22.5 million in 2022, then increased by 2.03% to $22.9 million in 2023, then increased by 9.16% to $25.0 million in 2024, then dropped by 7.56% to $23.1 million in 2025, then rose by 1.43% to $23.5 million in 2026.
- The last three Research & Development figures came in at $23.5 million (Q1 2026), $23.1 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 23.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.46 Mn |
| Dec 31, 2025 | 23.13 Mn |
| Sep 30, 2025 | 24.24 Mn |
| Jun 30, 2025 | 26.03 Mn |
| Mar 31, 2025 | 24.58 Mn |
| Dec 31, 2024 | 25.02 Mn |
| Sep 30, 2024 | 23.87 Mn |
| Jun 30, 2024 | 23.99 Mn |
| Mar 31, 2024 | 25.76 Mn |
| Dec 31, 2023 | 22.92 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 23.42 Mn |
| Mar 31, 2023 | 22.71 Mn |
| Dec 31, 2022 | 22.46 Mn |
| Sep 30, 2022 | 23.90 Mn |
| Jun 30, 2022 | 23.15 Mn |
| Mar 31, 2022 | 21.74 Mn |
| Dec 31, 2021 | 20.65 Mn |
| Sep 30, 2021 | 21.60 Mn |
| Jun 30, 2021 | 20.72 Mn |
| Mar 31, 2021 | 17.05 Mn |
| Dec 31, 2020 | 16.79 Mn |
| Sep 30, 2020 | 16.04 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Mar 31, 2020 | 15.95 Mn |
| Dec 31, 2019 | 16.38 Mn |
| Sep 30, 2019 | 16.08 Mn |
| Jun 30, 2019 | 16.26 Mn |
| Mar 31, 2019 | 15.55 Mn |
| Dec 31, 2018 | 15.81 Mn |
| Sep 30, 2018 | 14.79 Mn |
| Jun 30, 2018 | 13.98 Mn |
| Mar 31, 2018 | 13.89 Mn |
| Dec 31, 2017 | 13.91 Mn |
| Sep 30, 2017 | 13.55 Mn |
| Jun 30, 2017 | 13.70 Mn |
| Mar 31, 2017 | 13.77 Mn |
| Dec 31, 2016 | 13.28 Mn |
| Sep 30, 2016 | 12.77 Mn |
| Jun 30, 2016 | 11.64 Mn |
| Mar 31, 2016 | 11.25 Mn |
| Dec 31, 2015 | 10.98 Mn |
| Sep 30, 2015 | 11.32 Mn |
| Jun 30, 2015 | 10.81 Mn |
| Mar 31, 2015 | 10.87 Mn |
| Dec 31, 2014 | 10.03 Mn |
| Sep 30, 2014 | 9.15 Mn |
| Jun 30, 2014 | 7.64 Mn |
| Mar 31, 2014 | 7.68 Mn |
| Dec 31, 2013 | 7.92 Mn |
| Sep 30, 2013 | 7.70 Mn |
| Jun 30, 2013 | 7.18 Mn |
| Mar 31, 2013 | 7.22 Mn |
| Dec 31, 2012 | 7.40 Mn |
| Sep 30, 2012 | 7.45 Mn |
| Jun 30, 2012 | 7.29 Mn |
| Mar 31, 2012 | 7.12 Mn |
| Dec 31, 2011 | 6.84 Mn |
| Sep 30, 2011 | 6.67 Mn |
| Jun 30, 2011 | 6.47 Mn |
| Mar 31, 2011 | 6.30 Mn |
| Dec 31, 2010 | 6.60 Mn |
| Sep 30, 2010 | 6.62 Mn |
| Jun 30, 2010 | 6.25 Mn |
| Mar 31, 2010 | 6.33 Mn |
| Dec 31, 2009 | 6.39 Mn |
| Sep 30, 2009 | 6.15 Mn |